Health Care M&A Weekly Deals, The Week Ending November 10, 2017
We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Biotechnology Acquirer Target Price OncoResponse Paganini Biopharma N/A CERENIS Therapeutics LYPRO Biosciences Inc. N/A ClearLight Diagnostics, LLC License to IP relating to CLARITY N/A Home Health Care & Hospice Acquirer Target Price... Read More »Health Care M&A Weekly Deals, The Week Ending November 3, 2017
We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Biotechnology Acquirer Target Price Mereo BioPharma Group Ltd. License to AZD9668 $5 million Vaxart, Inc. Aviragen Therapeutics, Inc. $60 million Synthetic Genomics, Inc. Collaboration on RNA-based vaccines N/A Sarepta Therapeutics License... Read More »
